Fasting Study of Liothyronine Sodium Tablets (50 Mcg) to Cytomel® Tablets (50 Mcg)

Completed · Phase 1

Conditions studied: Healthy

In brief

The objective of this study was to investigate the bioequivalence of Mylan's liothyronine sodium 50 mcg tablets to King's Cytomel® 50 mcg tablets following a single, oral 100 mcg (2 x 50 mcg) dose administration under fasting conditions.

Key facts

Study ID

NCT00978055

Run by

Mylan Pharmaceuticals Inc

People needed

31

Starts

2007-10-01

Expected to finish

2007-12-01

Last updated by the study team

2009-09-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• healthy males and/or non-pregnant, non-lactating females, 18 years and older
• able to swallow medication

You may not qualify if…

• institutionalized subjects
• history of any significant disease
• use of any prescription or OTC medications within 14 days prior to start of study
• received any investigational products within 30 days prior to start of study

Where it is running

• PRACS Institute, Ltd. — Fargo, North Dakota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.